| answer text |
<p>The National Institute for Health and Care Excellence (NICE) is an independent
body and is responsible for the processes that it uses, in the development of its
recommendations on new medicines. The NICE will continue aiming to publish guidance
on new medicines within 90 days of the receipt of a United Kingdom marketing authorisation,
and is working closely with the Department, the Medicines and Healthcare products
Regulatory Agency, industry, and system partners to ensure that it is able to make
timely recommendations on new medicines licensed through the International Recognition
Procedure.</p>
|
 |
